Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers
Phase: N/A
Priority: Normal
Start: 05/11/20
End: 06/15/21
Due: 06/15/22
Phase: N/A
Priority: Normal
Start: 02/28/23
End: 04/08/24
Due: 04/08/25
Phase: N/A
Priority: Normal
Start: 06/24/24
End: 08/31/25
Due: 08/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers | NCT04392830 | AnnJi Pharmaceutical Co., Ltd. | user2@example.com | None | 2020-05-11 | 2021-06-15 | 2022-06-15 | - | - | 2025-07-14 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients | NCT05517603 | AnnJi Pharmaceutical Co., Ltd. | user2@example.com | None | 2023-02-28 | 2024-04-08 | 2025-04-08 | - | - | 2025-07-14 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers | NCT06625541 | AnnJi Pharmaceutical Co., Ltd. | user2@example.com | None | 2024-06-24 | 2025-08-31 | 2026-08-31 | - | - | 2025-07-14 |